OverviewChartNewsTraderScreen

BVT Call 120 NVO 20.12.2024/  DE000VM7SFA4  /

EUWAX
09/08/2024  08:22:32 Chg.+0.48 Bid21:59:57 Ask21:59:57 Underlying Strike price Expiration date Option type
1.54EUR +45.28% -
Bid Size: -		 -
Ask Size: -		 Novo Nordisk 120.00 USD 20/12/2024 Call
TeleTrader 07/08 Europe higher premarket amid earnings reports
TeleTrader 05/07 Novo Nordisk slammed over undisclosed payments
GlobeNewswire 02/07 Notified Celebrates Winners of 2024 IR Magazine European Awards
GlobeNewswire 28/06 SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteri...
GlobeNewswire 27/06 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 24/06 Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American ...
GlobeNewswire 18/06 Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesit...
GlobeNewswire 18/06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 17/06 Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Share...
TeleTrader 15/06 Novo Nordisk CEO to voluntarily testify before US committee
GlobeNewswire 14/06 Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
GlobeNewswire 13/06 Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire 13/06 Biosplice Announces Collaboration with Novo Nordisk in Diabetes
GlobeNewswire 11/06 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 10/06 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 10/06 Veru to Present at the American Diabetes Association's 84th Scientific Sessions
GlobeNewswire 03/06 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 03/06 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 31/05 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire 30/05 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 22/05 Veru to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 15/05 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire 15/05 Aeterna Zentaris Reports First Quarter 2024 Financial Results
GlobeNewswire 14/05 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Sci...
GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...